BOSTON (MedPage Today) -- The first clinical trial of direct antiviral drugs against hepatitis C virus (HCV) without interferon was a success, researchers said, though the FDA currently won't permit such a strategy in the U.S.
AASLD: Direct Antivirals Can Beat HCV Without Interferon (CME/CE...Courtesy MedPage Today Infectious Disease Thu, 11/05/2009 - 07:02
BOSTON (MedPage Today) -- The first clinical trial of direct antiviral drugs against hepatitis C virus (HCV) without interferon was a success, researchers said, though the FDA currently won't permit such a strategy in the U.S. Popular products More related itemsAASLD: High SVR Rates Seen with Telaprevir for...
AASLD: HCV Now an STD in New York (CME/CE)
Head-to-Head Trial Finds HCV Regimens Equal (CME/CE,...
Nasaline Nasal Irrigator
Wahl 9877-500 "The Goatee" Advanced Dual Blade,...
|
Popular by tags WeekMonth |
Post new comment